Sentence examples for trials of mortality from inspiring English sources

The two randomised trials of mortality are unaffected by bias and both show no effect of BSE on breast cancer mortality, after 5 or 13 years.

Delta inflation, a systematic overestimation in predictions of treatment effect size during trial design, is common in randomized controlled trials of mortality in critical care medicine.

Several parameters must be chosen by investigators in the design of a trial of mortality in order to determine the required sample size, including the significance level required for rejection of the null hypothesis; power; the predicted mortality rate in the placebo arm; and the predicted effect size (delta).

The results of this systematic review support evaluation of PMX-F in well-designed multicenter randomized controlled trials with comparison of mortality and cost-effectiveness in the context of best available sepsis care.

For mortality, we observed only an 11% relative risk increase in trials with low risk of bias and used this effect instead in the trial sequential analysis of mortality.

Hence a too rapid drop in A1C became another suspect for the higher mortality rate and led to an examination of change during the first year and even the first 4 months of the trial as predictors of mortality.

Single-center trials showed a greater benefit of GLN supplementation on mortality and overall infectious morbidity, although no signals of harm were observed in the multi-center trials of GLN on mortality.

The conclusion that mammography was not worthwhile was based on only one out of the six existing randomised trials of breast-cancer mortality comparing mammography with no screening.

Although a meta-analysis of these trials showed a reduction of mortality using higher PEEP levels in the most severe population [97], this does not constitute a definite proof but rather a hypothesis that would require another well-conducted, randomized trial to be confirmed.

Such variability creates confusion, leads to controversy and makes meta-analyses of trials with different times of mortality assessment difficult to interpret.

The DECREASE family of studies substantially contradict the meta-analysis of the secure trials on the effect of mortality (p=0.05 for divergence).